AEON AEON Biopharma, Inc.

Fundamentals / CIK 0001837607 / USD

AEON Biopharma, Inc. reported $14.13M in total assets and a net loss of $47.62M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AEON in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2021 to 2025), reported in USD.

$46.95M$23.48M$0-$52.71MFY 2021 Net Income: $8.20M2021FY 2022 Net Income: -$52.56M2022FY 2024 Net Income: $42.01M2024FY 2025 Net Income: -$39.22M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $4.09M $14.18M $34.75M --
Selling, General & Admin $12.21M $13.64M $13.68M --
Total Operating Expenses $12.80M -$72.98M $48.43M --
Operating Income -$12.80M $72.98M -$48.43M -$1.94M
EBITDA -$12.72M $73.08M -$48.36M --
Interest Income -- -- $3.71M $80K
Income Before Tax -$39.22M $42.01M -$52.56M $8.20M
Income Tax Expense $0 $0 $0 --
Net Income -$39.22M $42.01M -$52.56M $8.20M
Basic EPS -$3.95 $77.74 -$27.34 --
Diluted EPS -$3.95 $72.93 -$27.34 --
Basic Shares Outstanding 9.9M 540.4K 1.9M --
Diluted Shares Outstanding 9.9M 575.9K 1.9M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.51M $2.94M $2.03M $1.61M $597K $1.06M $825K $3.04M
Selling, General & Admin $2.99M $2.99M $3.90M $3.89M $1.93M $3.26M $3.12M $2.63M
Total Operating Expenses $4.48M $5.92M $5.93M $5.51M $2.49M $4.34M $462K $2.32M
Operating Income -$4.48M -$5.92M -$5.93M -$5.51M -$2.49M -$4.34M -$462K -$2.32M
EBITDA -$4.47M -$5.90M -$5.91M -$5.49M -$2.47M -$4.32M -$443K -$2.30M
Income Before Tax $2.46M -$1.16M -$11.79M -$37.14M -$4.54M -$6.64M $9.10M $2.08M
Net Income $2.46M -$1.16M -$11.79M -$37.14M -$4.54M -$6.64M $9.10M $2.08M
Basic EPS $0.01 -$0.02 -$0.29 -- -$0.39 -$0.60 $2.28 --
Diluted EPS $0.01 -$0.02 -$0.29 -- -$0.39 -$0.60 $2.28 --
Basic Shares Outstanding 90.0M 50.5M 40.6M -- 11.6M 11.1M 4.0M --
Diluted Shares Outstanding 90.0M 50.5M 40.6M -- 11.6M 11.1M 4.0M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $3.01M $13K $5.16M $9.75M $497K --
Cash & Short-Term Investments $3.01M $13K $5.16M $9.75M $497K --
Total Current Assets $3.40M $1.59M $6.22M $9.84M $835K $81K
Property, Plant & Equipment, Net $162K $235K $332K $431K -- --
Other Non-Current Assets $948K $29K $29K $34K -- --
Total Non-Current Assets $2.16M $1.55M $623K $940K $276.1M $0
Total Assets $5.56M $3.14M $6.84M $10.78M $276.9M $81K
Accounts Payable $942K $5.91M $3.39M $7.80M -- --
Total Current Liabilities $6.90M $14.15M $13.05M $82.57M $835K $60K
Total Non-Current Liabilities $53.69M $17.56M $146.8M $60.67M $17.04M $0
Total Liabilities $60.59M $31.71M $159.9M $143.2M $17.88M $60K
Total Debt (incl. Leases) $1.15M $1.27M $278K $499K -- --
Common Stock $9.0K $4.0K $4.0K $14K -- --
Retained Earnings -$470.8M -$431.6M -$473.6M -$474.8M -$16.96M -$3.6K
Total Stockholders' Equity -$55.03M -$28.57M -$153.0M -$287.5M -$16.93M $21K
Total Equity -$55.03M -$28.57M -$153.0M -$270.4M -$223.8M $21K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $11.42M $3.43M $6.24M $3.01M $5.93M $8.44M $10.45M $13K
Cash & Short-Term Investments $11.42M $3.43M $6.24M $3.01M $5.93M $8.44M $10.45M $13K
Total Current Assets $12.56M $3.99M $6.62M $3.40M $7.41M $10.26M $12.32M $1.59M
Property, Plant & Equipment, Net $58K $123K $142K $162K $181K $200K $220K $235K
Other Non-Current Assets $710K $863K $871K $948K $29K $29K $29K $29K
Total Non-Current Assets $1.57M $1.92M $2.00M $2.16M $1.32M $1.40M $1.48M $1.55M
Total Assets $14.13M $5.91M $8.63M $5.56M $8.73M $11.66M $13.80M $3.14M
Accounts Payable $981K $2.70M $1.48M $942K $2.52M $3.91M $2.44M $5.91M
Total Current Liabilities $4.57M $7.34M $6.67M $6.90M $8.23M $9.13M $8.64M $14.15M
Other Non-Current Liabilities $22K $23K -- -- -- -- -- --
Total Non-Current Liabilities $7.17M $13.93M $18.71M $53.69M $20.38M $18.39M $16.48M $17.56M
Total Liabilities $11.74M $21.27M $25.38M $60.59M $28.61M $27.51M $25.12M $31.71M
Total Debt (incl. Leases) $1.13M $1.02M $1.08M $1.15M $1.20M $1.26M $1.28M $1.27M
Common Stock $14K $10K $10K $9.0K $9.0K $9.0K $9.0K $4.0K
Retained Earnings -$481.3M -$483.8M -$482.6M -$470.8M -$433.7M -$429.1M -$422.5M -$431.6M
Total Stockholders' Equity $2.39M -$15.36M -$16.75M -$55.03M -$19.87M -$15.85M -$11.32M -$28.57M
Total Equity $2.39M -$15.36M -$16.75M -$55.03M -$19.87M -$15.85M -$11.32M -$28.57M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$39.22M $42.01M -$52.56M $8.20M
Depreciation & Amortization $78K $97K $68K --
Stock-Based Compensation $5.32M $6.25M $5.89M --
Change in Payables -$4.97M $2.52M $6.61M --
Operating Cash Flow -$17.31M -$20.29M -$35.58M -$1.49M
Capital Expenditure -$4.0K -- -$306K --
Free Cash Flow -$17.31M -- -$35.89M --
Investing Cash Flow -$4.0K -- -$306K -$276.0M
Common Stock Issued -- $147K -- $270.5M
Financing Cash Flow $20.30M $15.15M $40.51M $278.0M
Net Change in Cash $2.99M -$5.14M $4.62M $497K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $2.46M -$1.16M -$11.79M -$37.14M -$4.54M -$6.64M $9.10M $2.08M
Depreciation & Amortization $15K $20K $19K $20K $19K $20K $19K $23K
Stock-Based Compensation $1.56M $1.66M $1.93M $1.59M $414K $1.58M $1.73M $1.34M
Change in Payables -$1.72M $1.22M $539K -$1.58M -$1.38M $1.47M -$3.47M $1.28M
Operating Cash Flow -$5.72M -$3.70M -$2.64M -$4.71M -$2.60M -$2.09M -$7.91M -$621K
Capital Expenditure -- -- -- $0 $0 $0 -$4.0K --
Free Cash Flow -- -- -- -$4.71M -$2.60M -$2.09M -$7.91M --
Investing Cash Flow -- -- -- $0 $0 $0 -$4.0K --
Common Stock Issued -- $886K $1.67M -- -- -$18.26M $18.35M --
Financing Cash Flow $13.72M $886K $5.87M $1.79M $84K $84K $18.35M $97K
Net Change in Cash $7.99M -$2.81M $3.24M -$2.92M -$2.51M -$2.01M $10.43M -$524K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -705.4% 1336.9% -487.6% 3.0%
Current Ratio 0.49x 0.11x 0.12x 1.00x
Quick Ratio 0.44x 0.00x 0.12x 0.60x
Operating Income Growth (YoY) -117.5% -- -- --
Net Income Growth (YoY) -193.4% -- -740.9% --
EPS Growth (YoY) -105.1% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -1995.8% -- -- -- -- -- -- --
Return on Assets (ROA) -337.0% -924.2% -696.5% -705.4% 0.0% -14.0% 1225.6% 1336.9%
Current Ratio 2.75x 0.54x 0.99x 0.49x 0.90x 1.12x 1.43x 0.11x
Quick Ratio 2.50x 0.47x 0.94x 0.44x 0.72x 0.92x 1.21x 0.00x
Debt to Equity 0.47x -- -- -- -- -- -- --
Operating Income Growth (YoY) -- -- -- -- -- -102.8% -- --
Net Income Growth (YoY) -- -- -229.7% -1883.7% -- -104.0% -- --
EPS Growth (YoY) -- -- -112.7% -- -- -100.2% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001837607) · from December 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal